Nanotherapeutics

company

About

Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities,

  • 51 - 100

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$30M
Industries
Biopharma,Biotechnology,Manufacturing
Founded date
Jan 1, 1999
Number Of Employee
51 - 100
Operating Status
Active

Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities, and a proprietary pipeline. The Company's technologies can be used with all drug types ranging from small molecules to proteins and peptides. These technologies can be employed with new chemical entities or with generic drugs and can be used with the spectrum of existing drug types ranging from small synthetic molecules to large recombinant macromolecules.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$38M
Nanotherapeutics has raised a total of $38M in funding over 2 rounds. Their latest funding was raised on Sep 24, 2014 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 24, 2014 Debt Financing $8M 1 Detail
Jun 3, 2014 Debt Financing $30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Nanotherapeutics is funded by 2 investors. Trinity Capital and Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Trinity Capital Debt Financing
Hercules Capital Debt Financing